fingolimod hydrochloride has been researched along with ammonium hydroxide in 1 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (ammonium hydroxide) | Trials (ammonium hydroxide) | Recent Studies (post-2010) (ammonium hydroxide) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 29,152 | 577 | 9,136 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, S; Jin, Y; Ni, H; Xu, H; Zhang, Q | 1 |
1 other study(ies) available for fingolimod hydrochloride and ammonium hydroxide
| Article | Year |
|---|---|
Sphingosine-1-phosphate receptor agonist, FTY720, restores coronary flow reserve in diabetic rats.
Topics: Ammonia; Animals; Blood Glucose; Capillaries; Cell Adhesion Molecules; Collagen; Coronary Circulation; Coronary Disease; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Drug Evaluation, Preclinical; Fingolimod Hydrochloride; Gene Expression Regulation; Interleukin-6; Lysophospholipids; Male; Microcirculation; Myocardium; Nitrogen Radioisotopes; Positron-Emission Tomography; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Transforming Growth Factor beta | 2014 |